Gregor MacRae
Corporate Officer/Principal chez Appledore Wealth Management LLP
Profil
Gregor MacRae is a Senior Partner at Appledore Wealth Management LLP.
He was a Non-Executive Director at OKYO Pharma Ltd.
from 2019 to 2020 and at Tiziana Life Sciences Ltd.
(United Kingdom) in 2020.
He is a graduate of the University of Birmingham.
Postes actifs de Gregor MacRae
| Sociétés | Poste | Début |
|---|---|---|
| Appledore Wealth Management LLP | Corporate Officer/Principal | - |
Anciens postes connus de Gregor MacRae
| Sociétés | Poste | Fin |
|---|---|---|
Tiziana Life Sciences Ltd. (United Kingdom)
 Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | Directeur/Membre du Conseil | 18/06/2020 |
| OKYO PHARMA LIMITED | Directeur/Membre du Conseil | 10/06/2020 |
Formation de Gregor MacRae
| University of Birmingham | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| OKYO PHARMA LIMITED | Health Technology |
| Entreprise privées | 2 |
|---|---|
Tiziana Life Sciences Ltd. (United Kingdom)
Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | Health Technology |
| Appledore Wealth Management LLP |